[HTML][HTML] Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
J Bordat, S Maury, M Leclerc - Frontiers in immunology, 2023 - frontiersin.org
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
T Meejun, K Srisurapanont, K Manothummetha… - Blood Advances, 2023 - Elsevier
Immunogenicity of SARS-CoV-2 vaccination is diminished in hematopoietic stem cell
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …
transplant (HSCT) recipients. To summarize current evidence and identify risk factors for …
[HTML][HTML] SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
[HTML][HTML] Revised guidelines for coronavirus disease 19 management in hematopoietic cell transplantation and cellular therapy recipients (August 2022)
V Dioverti, Z El Boghdadly, Z Shahid… - … and Cellular Therapy, 2022 - Elsevier
This document is intended as a guide for diagnosis and management of Coronavirus
Disease 2019 (COVID-19), caused by the virus SARS-CoV-2, in adult and pediatric HCT …
Disease 2019 (COVID-19), caused by the virus SARS-CoV-2, in adult and pediatric HCT …
[HTML][HTML] Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
L Federico, THA Tvedt, M Gainullin, JR Osen… - Frontiers in …, 2023 - frontiersin.org
Poor overall survival of hematopoietic stem cell transplantation (HSCT) recipients who
developed COVID-19 underlies the importance of SARS-CoV-2 vaccination. Previous …
developed COVID-19 underlies the importance of SARS-CoV-2 vaccination. Previous …
[HTML][HTML] International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications
and international access improves, the number of HCTs performed annually continues to …
and international access improves, the number of HCTs performed annually continues to …
[HTML][HTML] HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients
J Villemonteix, V Allain, E Verstraete, D Jorge-Cordeiro… - Iscience, 2023 - cell.com
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients show lower
humoral vaccine responsiveness than immunocompetent individuals. HLA diversity …
humoral vaccine responsiveness than immunocompetent individuals. HLA diversity …
[HTML][HTML] Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
A Livieratos, C Gogos, K Akinosoglou - Viruses, 2024 - mdpi.com
Cellular and humoral immunity exhibit dynamic adaptation to the mutating SARS-CoV-2
virus. It is noteworthy that immune responses differ significantly, influenced by whether a …
virus. It is noteworthy that immune responses differ significantly, influenced by whether a …
mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses …
Allogeneic hematopoietic stem cell transplant (HCT) recipients are at high risk of severe
COVID-19 despite vaccination. Little is known about cellular response to SARS-CoV-2 …
COVID-19 despite vaccination. Little is known about cellular response to SARS-CoV-2 …
[HTML][HTML] Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE …
H Gao, J Wang, X Zheng, X Pei, Y Zheng… - Frontiers in Cellular …, 2024 - frontiersin.org
Introduction Retrospective studies have suggested that Ursodeoxycholic Acid (UDCA)
provide a protective effect against SARS-CoV-2 infection, particularly in patients with liver …
provide a protective effect against SARS-CoV-2 infection, particularly in patients with liver …